PRO-GUANFACINE XR DIN 02525240

Status: Marketed

Holder: PRO DOC LIMITEE

Molecule: GUANFACINE (GUANFACINE HYDROCHLORIDE)

Health Canada record

Active ingredient(s)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 3 MG
Dosage form	Tablet (Extended-Release)
Route	Oral
Schedule	PRESCRIPTION
Class	Human
ATC	C02AC02 GUANFACINE
Original market date	04-May-2026
Current status date	04-May-2026
Source	Health Canada DPD

Establishment licence of the holder

Pro Doc Limitée — licence 100182, currently licensed, last inspection rating C (2025-08-11).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing GUANFACINE (GUANFACINE HYDROCHLORIDE)

DIN	Product	Company	Form	Strength	Status
02525127	AG-GUANFACINE XR	ANGITA PHARMA INC.	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 1 MG	Marketed
02525151	AG-GUANFACINE XR	ANGITA PHARMA INC.	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 4 MG	Marketed
02525143	AG-GUANFACINE XR	ANGITA PHARMA INC.	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 3 MG	Marketed
02525135	AG-GUANFACINE XR	ANGITA PHARMA INC.	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 2 MG	Marketed
02523728	APO-GUANFACINE XR	APOTEX INC	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 1 MG	Marketed
02523736	APO-GUANFACINE XR	APOTEX INC	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 2 MG	Marketed
02523744	APO-GUANFACINE XR	APOTEX INC	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 3 MG	Marketed
02523752	APO-GUANFACINE XR	APOTEX INC	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 4 MG	Marketed
02409100	INTUNIV XR	TAKEDA CANADA INC	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 1 MG	Marketed
02409119	INTUNIV XR	TAKEDA CANADA INC	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 2 MG	Marketed
02409127	INTUNIV XR	TAKEDA CANADA INC	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 3 MG	Marketed
02409135	INTUNIV XR	TAKEDA CANADA INC	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 4 MG	Marketed
02523582	JAMP GUANFACINE XR	JAMP PHARMA CORPORATION	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 4 MG	Marketed
02523574	JAMP GUANFACINE XR	JAMP PHARMA CORPORATION	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 3 MG	Marketed
02523566	JAMP GUANFACINE XR	JAMP PHARMA CORPORATION	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 2 MG	Marketed
02523558	JAMP GUANFACINE XR	JAMP PHARMA CORPORATION	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 1 MG	Marketed
02525224	PRO-GUANFACINE XR	PRO DOC LIMITEE	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 1 MG	Marketed
02525232	PRO-GUANFACINE XR	PRO DOC LIMITEE	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 2 MG	Marketed
02525259	PRO-GUANFACINE XR	PRO DOC LIMITEE	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 4 MG	Marketed
02563185	SANDOZ GUANFACINE XR	SANDOZ CANADA INCORPORATED	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 1 MG	Marketed
02563193	SANDOZ GUANFACINE XR	SANDOZ CANADA INCORPORATED	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 2 MG	Marketed
02563207	SANDOZ GUANFACINE XR	SANDOZ CANADA INCORPORATED	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 3 MG	Marketed
02563215	SANDOZ GUANFACINE XR	SANDOZ CANADA INCORPORATED	Tablet (Extended-Release)	GUANFACINE (GUANFACINE HYDROCHLORIDE) 4 MG	Marketed

Notices of Compliance

NOC	Date	Submission	Reason
27603	2022-02-16	Abbreviated New Drug Submission (ANDS)	Administrative: Licensing Agreement Between Two Companies

Request a quote for PRO-GUANFACINE XR

How to read a Canadian DIN record